3-(二甲基氨基)-N-[3-[(4-羟基苯甲酰基)氨基]-4-甲基苯基]苯甲酰胺
![3-(二甲基氨基)-N-[3-[(4-羟基苯甲酰基)氨基]-4-甲基苯基]苯甲酰胺结构式](https://image.chemsrc.com/caspic/310/208260-29-1.png)
3-(二甲基氨基)-N-[3-[(4-羟基苯甲酰基)氨基]-4-甲基苯基]苯甲酰胺结构式
|
常用名 | 3-(二甲基氨基)-N-[3-[(4-羟基苯甲酰基)氨基]-4-甲基苯基]苯甲酰胺 | 英文名 | ZM 336372 |
|---|---|---|---|---|
| CAS号 | 208260-29-1 | 分子量 | 389.447 | |
| 密度 | 1.3±0.1 g/cm3 | 沸点 | 484.4±45.0 °C at 760 mmHg | |
| 分子式 | C23H23N3O3 | 熔点 | N/A | |
| MSDS | 中文版 美版 | 闪点 | 246.8±28.7 °C |
|
Activation of protein kinase A (PKA) by 8-Cl-cAMP as a novel approach for antileukaemic therapy.
Br. J. Cancer 91 , 186-92, (2004) Activation of PKA by cAMP agonists, such as 8-Cl-cAMP activation, selectively causes rapid apoptosis in v-abl transformed fibroblasts by inhibiting the Raf-1 kinase. Here we investigated whether 8-Cl-cAMP is useful for the treatment of chronic myelogenous leu... |
期刊文献综述：
更多...